Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“A 2011 study found that 8.9 percent of marijuana users developed a dependence disorder, compared with 67.5 percent of nicotine users, 22.7 percent of alcohol users, and 20.9 percent of cocaine users.”
UnverifiableConfidence: LOW

Reasoning

The claim's numbers are repeated in a Reason.com article excerpt, which supports the statement. However, the excerpt does not link to or quote the original study, and no additional independent sources are presented to confirm the figures. Without access to the primary study, the claim cannot be verified.

On confidence: The only evidence is a secondary report excerpt that cites the numbers, but the original 2011 study is not provided or verifiable.

Important context

The excerpt is from a secondary source discussing drug policy and references a 2011 study, but it does not provide methodological details, sample size, or citation of the original research.

Evidence

Supporting (1)

  • Tier 3 — Secondary reporting
    The way the FDA and DEA ban drugs is unaccountable and arbitrary

    bend the concept of abuse potential without accountability. When the DEA rejected a petition to reschedule marijuana in 2016, it cited marijuana's widespread use as evidence of its potential for abuse, without providing quantitative…

Limitations

Reliance on a single secondary source; no direct access to the 2011 study; cannot assess the study's methodology, peer‑review status, or accuracy of the reported percentages.

Last verified:
Oct 1, 2026, 4:11 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

The Way the FDA and DEA Ban Drugs Is Unaccountable and Arbitrary

Reason · Ryan Curtis